Product
Lyumjev
2 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 1Indication
Type 1 DiabetesClinical trial
Effectiveness of a Basal Rate Reduction With LyumjevTM Versus Humalog® on the Protection From Exercise-Induced Hypoglycemia in Individuals With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionStatus: Completed, Estimated PCD: 2023-03-07
Clinical trial
A Randomized, Crossover, Pilot Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 DiabetesStatus: Recruiting, Estimated PCD: 2024-12-01